Notch1 modulates timing of G1-S progression by inducing SKP2 transcription and p27Kip1 degradation

被引:148
作者
Sarmento, LM
Huang, H
Limon, A
Gordon, W
Fernandes, J
Tavares, MJ
Miele, L
Cardoso, AA
Classon, M
Carlesso, N [1 ]
机构
[1] Harvard Univ, Sch Med, Ctr Regenerat Med & Technol, Boston, MA 02129 USA
[2] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Ctr Canc, Boston, MA 02129 USA
[3] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02129 USA
[4] Univ Lisbon, IMM, P-1649028 Lisbon, Portugal
[5] Sci Res Lab Inc, Somerville, MA 02143 USA
[6] Univ Illinois, Dept Pharmacodynam, Chicago, IL 60612 USA
关键词
D O I
10.1084/jem.20050559
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Cyclin-dependent kinase inhibitors (CKIs) and Notch receptor activation have been shown to influence adult stem cells and progenitors by altering stem cell self-renewal and proliferation. Yet, no interaction between these molecular pathways has been defined. Here we show that ligand-independent and ligand-dependent activation of Notch1 induces transcription of the S phase kinase-associated protein 2 (SKP2), the F-box subunit of the ubiquitin-ligase complex SCFSKP2 that targets proteins for degradation. Up-regulation of SKP2 by Notch signaling enhances proteasome-mediated degradation of the CKIs, p27(Kip1) and p21(Cip1), and causes premature entry into S phase. Silencing of SKP2 by RNA interference in G(1) stabilizes p27(Kip1) and p21(Cip1) and abolishes Notch effect on G(1)-S progression. Thus, SKP2 serves to link Notch1 activation with the cell cycle machinery. This novel pathway involving Notch/SKP2/CKIs connects a cell surface receptor with proximate mediators of cell cycle activity, and suggests a mechanism by which a known physiologic mediator of cell fate determination interfaces with cell cycle control.
引用
收藏
页码:157 / 168
页数:12
相关论文
共 45 条
  • [31] When protein destruction runs amok, malignancy is on the loose
    Pagano, M
    Benmaamar, R
    [J]. CANCER CELL, 2003, 4 (04) : 251 - 256
  • [32] G1 EVENTS AND REGULATION OF CELL-PROLIFERATION
    PARDEE, AB
    [J]. SCIENCE, 1989, 246 (4930) : 603 - 608
  • [33] Exclusive development of T cell neoplasms in mice transplanted with bone marrow expressing activated Notch alleles
    Pear, WS
    Aster, JC
    Scott, ML
    Hasserjian, RP
    Soffer, B
    Sklar, J
    Baltimore, D
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1996, 183 (05) : 2283 - 2291
  • [34] Notch signaling is a direct determinant of keratinocyte growth arrest and entry into differentiation
    Rangarajan, A
    Talora, C
    Okuyama, R
    Nicolas, M
    Mammucari, C
    Oh, H
    Aster, JC
    Krishna, S
    Metzgers, D
    Chambon, P
    Miele, L
    Aguet, M
    Radtke, F
    Dotto, GP
    [J]. EMBO JOURNAL, 2001, 20 (13) : 3427 - 3436
  • [35] The intracellular form of notch blocks transforming growth factor β-mediated growth arrest in Mv1Lu epithelial cells
    Rao, P
    Kadesch, T
    [J]. MOLECULAR AND CELLULAR BIOLOGY, 2003, 23 (18) : 6694 - 6701
  • [36] EPSTEIN-BARR-VIRUS NUCLEAR-PROTEIN 3C MODULATES TRANSCRIPTION THROUGH INTERACTION WITH THE SEQUENCE-SPECIFIC DNA-BINDING PROTEIN J-KAPPA
    ROBERTSON, ES
    GROSSMAN, S
    JOHANNSEN, E
    MILLER, C
    LIN, J
    TOMKINSON, B
    KIEFF, E
    [J]. JOURNAL OF VIROLOGY, 1995, 69 (05) : 3108 - 3116
  • [37] Induction of cyclin D1 transcription and CDK2 activity by Notchic:: Implication for cell cycle disruption in transformation by Notchic
    Ronchini, C
    Capobianco, AJ
    [J]. MOLECULAR AND CELLULAR BIOLOGY, 2001, 21 (17) : 5925 - 5934
  • [38] CDK inhibitors:: positive and negative regulators of G1-phase progression
    Sherr, CJ
    Roberts, JM
    [J]. GENES & DEVELOPMENT, 1999, 13 (12) : 1501 - 1512
  • [39] A CDK-independent function of mammalian Cks1:: Targeting of SCFSkp2 to the CDK inhibitor p27Kip1
    Spruck, C
    Strohmaier, H
    Watson, M
    Smith, APL
    Ryan, A
    Krek, W
    Reed, SI
    [J]. MOLECULAR CELL, 2001, 7 (03) : 639 - 650
  • [40] Sriuranpong V, 2001, CANCER RES, V61, P3200